 |
|
April
2006
|
 |
Why Are You Getting This Newsletter?
This free e-mail newsletter is sent to current and
former clients of our law firm, to those who
have specifically asked to receive it, and to
those who have contacted our firm for legal
advice in the past.
If the newsletter is being sent to you
in error, please follow the instructions at
the bottom of this page and you will
immediately be removed from our list of
subscribers.
If you know someone who might enjoy receiving
this free e-mail newsletter, please send us that
person's e-mail address.
Kraft & Associates will never sell or give
your e-mail information to anyone outside our
law firm. |
|
Guidant Defibrillators
In 2005, the Guidant Corporation recalled
several models of cardiac defibrillators and
cardiac pacemakers because of the risk of
potentially fatal malfunctions of these
devices.
There are approximately 38,000 patients in
the United States with Guidant brand
defibrillators. Reports indicate these
devices have failed at least 45 times and
have been responsible for at least two
deaths. Several Guidant defibrillator models
are on the recall list.
Contact our office for more information
regarding the Guidant defibrillator recall.
Free Legal Advice?
Yes, at Kraft &
Associates we are glad to provide our clients
and friends with free information on a variety
of subjects. If you want details about how to
lower your automobile insurance rates,
Texas Workers' Compensation law or
Social Security Disability claims, please
contact us and we will send you any of these
brochures without charge or obligation. |
|
 |
| |
|

Suite 1300
2777 Stemmons Freeway
Dallas, TX 75207
(214) 999-9999
(817) 999-9999
(800) 989-9999
|
|
 |
|
FOR THE RECORD |
 |
|
|

Fosamax Health Warning
There is a potentially very dangerous side
effect from taking a drug that
supposedly strengthens bones. This drug
is frequently taken by older women who
suffer from osteoporosis.
Fosamax®
(generic name - Alendronate) is a type
of drug known as bisphosphonates.
Recently a link has been found between
bisphosphonates and a serious bone
disease called osteonecrosis of the jaw
(ONJ, or "Dead Jaw"). This important
discovery clearly shows that Fosamax
side effects may include "dead jaw."
A report published in the Journal of
Oral and Maxillofacial Surgeons prompted
the United States Food and Drug
Administration and Novartis,
the manufacturer of bisphosphonates used
in cancer chemotherapy, to issue a
warning to health care professionals.
The warning letter contained information
about bisphosphonates and the risks of
osteonecrosis in the jaw.
Bisphosphonates such as Fosamax
(Alendronate Sodium), Zometa
(Zoledronate), Didronel (Etidronate),
Aredia (Pamidronate), Actonel
(Risedronate), and Boniva (Ibandronate)
are commonly used to treat, prevent, and
even to reverse bone loss associated with
osteoporosis, chemotherapy, and other
bone loss disorders. The strongest forms
of bisphosphonates are commonly used in
the management of advanced cancers that
have metastasized to the bone -- where the
disease often causes bone pain and
possibly even causes fractures. Several cancers
can involve or metastasize to the bone,
including lung cancer, breast cancer,
prostate cancer, multiple myeloma, and
others. When bisphosphonates are given
in cancer chemotherapy, the drugs are
given intravenously, and usually for
longer periods of time.
Osteonecrosis of the Jaw
Osteonecrosis of the jaw is a condition in
which the bone tissue in the jaw fails
to heal after minor trauma such as a
tooth extraction, causing the bone to be
exposed. The exposure can eventually
lead to infection and fracture, and may
require long-term antibiotic therapy or
surgery to remove the dying bone tissue.
Experts say that prevention and early
treatment of individuals using
bisphosphonates such as Fosamax is
extremely important in preserving the
jaw bone. Individuals using Fosamax or
other bisphosphonates should attempt to
avoid tooth extractions and other major
dental work while on the drugs.
Although most cases of osteonecrosis of
the jaw related to Fosamax side effects
have occurred after dental work, several
cases have been reported without any
prior dental work. If you are currently
taking Fosamax you may be at risk of
developing osteonecrosis. If you have
been injured by Fosamax side effects you
may be entitled to compensation.
The symptoms of osteonecrosis of the jaw
include:
• Severe infections
• Loosening of teeth
• Swelling around the jaw
If you or a loved one have taken Fosamax
and have been injured as a result of
Fosamax side effects such as
osteonecrosis of the jaw, please contact
our law firm immediately. You should
never discontinue the use of any
prescription drug without discussing
your concerns with your doctor.
|
|
|
|
| FOR
YOUR INFORMATION |
 |
|
|
Cautions About
Zyprexa
Zyprexa® is an anti-psychotic medication
that was approved in 1996 by the United
States Food and Drug Administration
for the treatment of schizophrenia. It is a
member of a class of drugs referred to as
"second generation anti-psychotics" ("SGAs")
or "atypical anti-psychotics." When Zyprexa®
was approved, there were two other such SGA
medications already available on the market.
Consequently, Zyprexa is considered a
"me-too" drug, joining a class of existing
medications prescribed for the treatment of
common disorders.
The SGAs were developed as an alternative to
the so-called "first generation
anti-psychotics" ("FGAs"). The SGAs were
designed to be more effective in the
treatment of anti-psychotic disorders, with
fewer of the side effects generally
associated with the use of FGAs. Of the six
SGA's currently available, Zyprexa is the
most commonly prescribed. The generic name
of Zyprexa is olanzapine.
In September 2003, the Food and Drug
Administration ordered the manufacturer
to revise the label of Zyprexa by adding a
warning that "hyperglycemia, in some cases
extreme and associated with ketoacidosis or
hyperosmolar coma or death, has been
reported in patients treated with atypical
anti-psychotics." Among the more serious
outcomes resulting from hyperglycemic
abnormalities are:
• Diabetes
• Diabetic Ketoacidosis
• Diabetic Coma
• Hyperosmolar Coma
• Hyperglycemia
If you are currently taking Zyprexa and
have concerns about its safety, you should
consult with your doctor regarding your
treatment options. Under no circumstances
should you discontinue taking any
medication, including Zyprexa, without
first consulting with your doctor.
If you or a loved one have taken Zyprexa and
have experienced severe Zyprexa side
effects, or have questions about a possible
Zyprexa claim, please contact our firm.
|
|
| FEATURED
EMPLOYEE |
 |
|
|
Jo-Ann
Martinez
Social Security Secretary
E-mail:
jmartinez@kraftlaw.com
Ms.
Martinez joined our firm in 1995 as a receptionist.
Ms. Martinez has filled several positions with our
firm over the years and currently works as a legal
secretary in our Social Security department. She also
serves as one of that department's Spanish-English
translators. Ms. Martinez has more than 20 years'
experience as a receptionist and legal secretary. |
|
| FEATURED
CASE |
 |
|
Latest Developments
In Vioxx Litigation
Our law firm is currently accepting claims
on behalf of consumers who took the
arthritis drug Vioxx, and then suffered a
heart attack or stroke. For that reason, we
have been keeping a close watch on the Vioxx
trials taking place around the country.
A jury this month awarded $9 million in punitive
damages to a New Jersey man who blamed Merck & Company's Vioxx for his heart attack.
The punitive damages came on top of $4.5 million in
compensatory damages the jury awarded 77-year-old
John McDarby after they found that Vioxx was a
significant contributing factor to his heart attack,
and that Merck failed to adequately warn of the
drug's risks. Merck, which pulled the $2.5
billion-a-year drug off the market in September
2004, said it would appeal the verdicts.
In awarding the punitive damages, the jury
determined that Merck withheld material information
on Vioxx from the U.S. Food and Drug Administration
and the company's actions were deliberately meant to
harm.
As part of its deliberations, the jury considered
whether Merck intentionally withheld from regulators
an analysis of several clinical trials done by a
company statistician in 2000 that showed a higher
incidence of heart attacks among patients taking
Vioxx than those taking other drugs.
Merck expressed disappointment over the jury's
decision but gave no indication that it was willing
to consider settling any of the thousands of
lawsuits it is facing. So this result is good news
for anyone with a potential claim against Vioxx,
but it does not mean that Merck is going to offer to
settle any Vioxx cases in the near future. |
|
| HOW
CAN WE HELP YOU? |
 |
|
Our law firm has helped thousands of clients
over the years. Sometimes clients who use
our firm for one type of case may not
realize that there are other legal problems
we could help them solve.
We handle
most types of injury claims — including
automobile collisions, "slip and fall"
cases, injuries suffered as a result of
defective products, injuries resulting from
inadequate security, medical malpractice
claims, nursing home negligence claims,
prescription drug injuries and many others.
We invite you to call us about any
serious injury to see how we can help you.
Kraft & Associates also represents people
who have been denied their Social Security
Disability benefits. We can help at the
Initial stage, the Reconsideration stage or
the Hearing stage.
Our firm represents people who have been injured on
the job and are making a claim for workers'
compensation. We help people who have problems
regarding family issues, such as divorce, child
support, adoption, modifications, enforcements,
attorney general disputes, paternity and other similar
matters. We also represent clients who have been
arrested or charged with committing a crime.
Please feel free to call us with any
legal questions you may have. If we cannot
represent you, we will attempt to refer you
to another attorney or to a government
agency that can help you. There is never any
charge or obligation for our initial
consultation. |
|
Share
this Site with a Friend:
You
have received this newsletter because of your previous
contact with our law firm.
To remove your name from future mailings, please notify
us.
Please
send mail to info@kraftlaw.com
with questions or comments.
Copyright
© 1997- 2006 Kraft & Associates : Injury &
Disability Lawyers, P.C. All Rights Reserved Worldwide. Personal Injury,
Automobile Accident, Wrongful Death, Nursing Home Negligence,
Social Security Disability.
DISCLAIMER:
This newsletter is presented by Kraft & Associates for
informational purposes only, and not as legal advice.
|
|
|
|